Nonsense-mediated mRNA decay factor SMG8 (SMG8)

Nonsense-mediated mRNA decay factor SMG8 (SMG8) is a regulatory protein that is part of the SMG-1 kinase complex, which plays a central role in nonsense-mediated mRNA decay (NMD), a critical mRNA surveillance pathway that eliminates transcripts containing premature termination codons[1][2][3]. SMG8 functions in two main ways: it suppresses the kinase activity of SMG-1 and helps recruit SMG-1 to the mRNA surveillance complex (SURF) associated with ribosomes stalled at premature stop codons[1][2]. By controlling the phosphorylation of Upf1, a key step in NMD, SMG8 ensures that only aberrant mRNAs are targeted for degradation. Genetic or RNAi-mediated knockdown of SMG8 can inhibit NMD and stabilize mutant, PTC-containing mRNAs, which can be therapeutically beneficial in certain genetic diseases where partial protein function is desirable, such as selected muscular dystrophies or genetic leukoencephalopathies[1]. SMG8 has also been linked to certain cancers, likely due to its chromosomal location and amplification, but it is not a classical oncogene or receptor. No drugs are currently known to specifically target SMG8, but it is a promising focus for future therapeutics aimed at modulating NMD for genetic disease correction[1][2][3].

Other names

SMG8ABC2C17orf71FLJ10587FLJ23205Amplified in breast cancer gene 2 proteinProtein SMG-8 homologALKUS

Inhibition of SMG8 suppresses NMD, leading to stabilization of mRNAs with premature termination codons and potential rescue of mutant protein expression[1][2]